Position in AMGN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,084,549
+$30,407 QoQ
Shares Held
2,995
-0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.27%
of 13F equity value
Holder Rank
#1,650
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Kendall Capital Management holds $22,925,368 across 11 Drug Manufacturers - General names. AMGN ranks #7 (4.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
24,818 | $6,245,201 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
69,150 | $3,984,423 | |
| 3 | GSK |
GSK plc
|
50,941 | $2,670,327 | |
| 4 | MRK |
Merck & Co., Inc.
|
19,682 | $2,529,137 | |
| 5 | JNJ |
Johnson & Johnson
|
8,136 | $2,066,299 | |
| 6 | PFE |
Pfizer Inc
|
49,545 | $1,193,043 | |
| 7 | AMGN |
Amgen Inc
This page
|
2,995 | $1,084,549 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
8,362 | $1,056,455 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,084,549 | 2,995 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $1,054,142 | 2,996 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $980,948 | 2,997 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $851,397 | 3,017 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $867,505 | 3,107 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $958,016 | 3,075 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $805,377 | 3,090 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $1,269,507 | 3,940 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $1,284,169 | 4,110 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $1,286,832 | 4,526 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $1,330,940 | 4,621 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $1,287,629 | 4,791 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $1,070,358 | 4,821 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $1,080,864 | 4,471 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,182,930 | 4,504 | Shares | Sole | 2023-01-30 | |
| 2022-09-30 | $1,028,725 | 4,564 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $1,116,503 | 4,589 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $1,127,848 | 4,664 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $1,017,764 | 4,524 | Shares | Sole | 2022-01-28 | |
| 2021-09-30 | $962,028 | 4,524 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $1,100,531 | 4,515 | Shares | Sole | 2021-07-30 | |
| 2021-03-31 | $1,076,103 | 4,325 | Shares | Sole | 2021-05-05 | |
| 2020-12-31 | $994,404 | 4,325 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $1,142,449 | 4,495 | Shares | Sole | 2020-10-22 | |
| 2020-06-30 | $1,337,326 | 5,670 | Shares | Sole | 2020-07-30 | |
| 2020-03-31 | $1,223,070 | 6,033 | Shares | Sole | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||